Randomized Clinical Trial, Double-blind, Single-dose Drug and Escalating Infection Intensities, Evaluating the Safety and Efficacy of Moxidectin 2 mg, Ivermectin-controlled, in Loa Loa Microfilaremic Patients
Latest Information Update: 28 Feb 2025
At a glance
- Drugs Moxidectin (Primary) ; Ivermectin
- Indications Filariasis; Loiasis
- Focus Adverse reactions
- Acronyms EOLoa
Most Recent Events
- 24 Feb 2025 Status changed from active, no longer recruiting to completed.
- 07 Jul 2023 Planned End Date changed from 30 Jun 2023 to 14 Aug 2023.
- 07 Jul 2023 Planned primary completion date changed from 28 Feb 2023 to 14 Aug 2023.